{"disease":{"id":"traumatic-optic-neuropathy","name":"traumatic optic neuropathy"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03308448","title":"Traumatic Optic Neuropathy Treatment Trial 2","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":93,"lead_sponsor_name":"Iran University of Medical Sciences","has_results":false},{"nct_id":"NCT05140486","title":"Targeted Shortwave Diathermy Combined With Perceptual Training for Patients With Severe Traumatic Optic Neuropathy","phase":"NA","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"Hunan Provincial People's Hospital","has_results":false},{"nct_id":"NCT06168188","title":"The Neuroprotective Effect of PEG-GCSF in the Traumatic Optic Neuropathy","phase":"EARLY_PHASE1","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"Buddhist Tzu Chi General Hospital","has_results":false},{"nct_id":"NCT05353413","title":"Diffusion Weighted Magnetic Resonance Imaging and the Optic Nerve Neuropathy.","phase":"NA","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"Medical University of Bialystok","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}